2008; Schultz-Cherry, Sissoko, Neumann, Kawaoka, & Hinshaw, 2001; Zhirnov, Konakova, Wolff, & Klenk, 2002) . Several studies showed that NS1 specifically derived from H5 subtypes can induce apoptosis in human cells (Lam, Yeung, & Chan, 2011; Lam et al., 2008; Mukherjee, Majumdar, Vipat, Mishra, & Chakrabarti, 2012) . However, other studies demonstrated the suppression of apoptotic events by NS1 protein specifically derived from H1 subtypes in mammalian hosts (Ehrhardt et al., 2007; Schultz-Cherry et al., 2001) . Clearly, these observations were dependent on virus strain and cellular host system used for the study. The mode of NS1 expression in host cells (i.e., through infection or transfection) also seems to determine its apoptotic modulating response (Yan et al., 2016; Zhang et al., 2010; Zhirnov et al., 2002) .
The induction of apoptosis by NS1 protein was shown to be IFNdependent through the activation of NF-ĸB in some cases or IFN-independent through activation of caspases by different mechanisms in other cases (Ehrhardt et al., 2007; Pauli et al., 2008; Zhirnov et al., 2002) .
Recently, we demonstrated that JNK activation in the course of IAV infection is predominantly mediated by NS1 in a virus subtypespecific manner. Although NS1 of most virus subtypes was able to activate JNK, the NS1 of IAV PR8 failed to do so. Subsequent investigations identified the amino acid (aa) at position 103 of NS1 playing a critical role in this signalling event (Nacken et al., 2014) .
Interestingly, the expression of NS1 of IAV PR8, which fails to induce apoptosis, also failed to activate JNK (Nacken et al., 2014) , further supporting a potential correlation between JNK activation and apoptosis in IAV-infected cells. Because both NS1 and JNK interfere with apoptosis, we asked whether NS1-mediated JNK activation might be the trigger of IAV-induced apoptosis.
To study this issue, we fuse the NS1 protein with the widely known mutated form of the ligand-binding domain of the oestrogen receptor ER(T2), ERT, domain (Feil et al., 1996) . The constitutively expressed NS1 oestrogen receptor (NS1ERT) protein is inactive under standard cultivation conditions, but can be activated upon the addition of 2-hydroxy-tamoxifen. This strategy allowed us to investigate the correlation between the NS1-mediated JNK activation and the potential of NS1 to induce apoptosis.
| RESULTS

| Tamoxifen converts the inactive NS1ERT fusion protein into a functionally competent NS1
We recently identified IAV NS1 protein as an activator of the stressrelated kinase JNK (Nacken et al., 2014) . Both JNK and NS1 are known to be involved in apoptosis induction, suggesting that NS1-mediated JNK activation and apoptosis induction might be functionally connected to each other. In the search for a cellular model to study NS1 functions detached from the virus-driven infection process, we realised that constitutive expression of NS1 per se is toxic to the host cell. Thus, we established a cellular model that allows the expression of a conditionally functional NS1.
The NS1 gene of the IAV SC35M subtype was fused with the ERT domain, mutated ERT ligand-binding domain ER(T2). The ERT domain has been widely used, especially in mouse genetics, to generate tamoxifen-inducible versions of specific proteins (Friedel, Wurst, Wefers, & Kühn, 2011) . The chimeric NS1ERT protein was constitutively FIGURE 1 Induction of the stably expressed NS1 oestrogen receptor (NS1ERT) fusion protein by tamoxifen induces c-Jun N-terminal kinase (JNK) activation. (a) A schematic map of the transduced constructs is shown. The coding sequence of the influenza nonstructural protein (NS1) has been fused to the tamoxifen-responsible mutated estrogenbinding domain of the estrogen receptor oestrogen receptor (ER) alpha (ERT). Listed are all wild type and mutant NS1 ERT fusion constructs used in this study. (b) Madin-Darby canine kidney epithelial (MDCK) cells expressing the 60 kD NS1ERT (SC35M) fusion-protein were incubated with tamoxifen for the time indicated. Subsequently cell lysates were isolated and analyzed via western blotting. x = site of mutation, aa = amino acids, PLEG = amino acid sequence of the linker; P-JNK = phosphorylated or activated JNK; NS1 = influenza A virus NS1 protein; ERK2 = loading control, nt = nontreated control expressed in Madin-Darby canine kidney epithelial (MDCK) cells (MDCK-NS1ERT-SC35M), which are known to be highly susceptible to IAV infection and replication. Figure 1a shows a schematic representation of the NS1ERT fusion. To exclude virus-and cell-type specific effects, in addition to MDCK cells, we also generated A549 NS1ERT-PR8), of Panama (H3N2; NS1ERT-Panama), and of Thai/Kan (H5N1; NS1ERT-Thai/Kan), as well as of some SC35M NS1 mutants (H7N7; Figure 1a ).
To demonstrate that the NS1ERT fusion protein represents a conditionally active NS1 protein, three parameters were investigated: the activation of JNK, the rescue of attenuated replication of NS1-deficient IAVs, and the inhibition of interferon up-regulation.
First, because NS1-mediated activation of JNK was a focus of this study and has been shown previously (Nacken et al., 2014) , the activation of this kinase was analysed in NS1ERT-expressing cells.
After stimulation of the cells with tamoxifen, JNK phosphorylation was found to be steadily increasing with time ( Figure 1b) , suggesting that the ERT domain indeed blocks NS1 functions and that the addition of tamoxifen restores functional NS1.
Second, given that the NS1ERT protein is functionally competent after tamoxifen induction, MDCK cells expressing the chimeric protein should be able to rescue, upon tamoxifen addition, the attenuated replication of IAV viruses that are deficient for NS1. Thus, we used the NS1-deficient delta-NS1 PR8 strain to infect MDCK control cells and MDCK-NS1ERT-PR8 cells with NS1-deficient delta-NS1 PR8 strain in the presence and absence of tamoxifen. As expected, after infection with PR8-delta-NS1, the virus yield of tamoxifen-induced MDCK-NS1ERT-PR8 cells was higher than that of noninduced MDCK control cells (Figure 2a) . We extended this analysis by using MDCK cells expressing NS1ERT fusions that encode NS1 genes from different IAV subtypes. Virus titres of supernatants from these cells were almost two 1.5 log steps higher compared to those of control cells suggesting that either NS1 complementation of the delta NS1 PR8 is more efficient when the NS1-encoding gene originates from a virus subtype other than PR8 or that the level of functional NS1ERT differs (Figure 2b ).
NS1 protein of PR8 is reportedly unable to bind to cleavage and polyadenylation specificity factor (CPSF30; Steidle et al., 2010) . Interestingly, the virus titre was reduced in cells expressing a mutant NS1ERT SC35M 184-188 that is unable to bind CPSF30.
NS1-deficient IAVs of subtypes other than PR8 (H1N1) do not or poorly replicate in MDCK cells. Here, we infected MDCK-NS1ERT-FIGURE 2 Tamoxifen-induced NS1 oestrogen receptor (NS1ERT) fusion protein functionally complements replication of PR8-delta-NS1 and attenuates interferon induction by viral RNA. (a) Madin-Darby canine kidney epithelial (MDCK) wild type cells (wt). MDCK cells expressing NS1 oestrogen receptor (PR8; NS1ERT-PR8) were infected with 0.5 MOI PR8-delta-NS1 for 48 hr and incubated with (+) or without (−) 0.5 μM tamoxifen (OHT). Virus titers were determined via plaque assay. B: PR8-delta-NS1 was used to infect control MDCK (ctr) cells, those expressing NS1ERT (Thai/Kan; Thai), NS1ERT SC35M (SC35M), NS1ERT SC35M 184-188 mutant (184-188), NS1ERT (Panama), and cells containing an empty vector control. All cells were incubated with tamoxifen for 48 hr upon infection. Virus titres were determined via plaque assay. (c) Empty vector control MDCK cells (vector) and those expressing NS1ERT SC35M (NS1ERT) were infected with 0.5 MOI SC35M wild type IAV (wt) and SC35M delta-NS1 IAV (ΔNS1). All cells were incubated with tamoxifen for 48 hr. Virus titers were determined via standard plaque assay. (d) A549 cells expressing NS1ERT SC35M were transfected with an interferon promoter driven luciferase reporter construct (pTATA luc-IFN-β). Next day, cells were transfected either with cellular RNA (−) or RNA of IAV-infected cells (+) and treated without tamoxifen. Cells were harvested 4 hr after RNA stimulation. vRNA: total RNA of IAV-infected cells; OHT: tamoxifen (0.5 μM). Each experiment was repeated at least five times. *p value < .05 (n = 4, avg ± std) SC35M as well as control MDCK cells with wild type SC35M and delta-NS1 SC35M IAV (H7N7). A roughly 500-fold higher titre was observed using tamoxifen-treated MDCK-NS1ERT-SC35M cells compared to tamoxifen-treated control MDCK cells. Of note, the titre of the delta NS1-SC35M IAV grown in complementing MDCK-NS1ERT-SC35M cells that was still more than two log steps lower than the titre obtained with wild type SC35M IAV (Figure 2c ).
Third, one of the main functions of NS1 is the suppression of retinoic acid inducible gene I (RIG-I)-mediated interferon stimulation upon infection (Ayllon & García-Sastre, 2015) . Thus, A549-NS1ERT (SC35M) cells were stimulated with viral RNA and interferon promoter-driven luciferase activity was investigated with and without tamoxifen. Tamoxifen treatment caused a significant reduction of luciferase activity (Figure 2d ), further confirming that the NS1-ERT fusion protein represents a conditionally active NS1 functions inducible with tamoxifen.
2.2 | Tamoxifen addition to MDCK cells expressing NS1ERT induces a cytopathic phenotype depending on the IAV strain from which the NS1 originates A virus-mediated cytopathic effect often correlates with or relies on the inhibition of host cell gene expression (Lyles, 2000) . To Figure 6a) ; however, no signs of apoptosis could be detected (Figures 5b,c and 6b) . Thus, the expression of functional NS1 IAV protein (except PR8) in mammalian (e) Minigenome assay was performed using MDCK-NS1ERT-SC35M cells. Cells were transfected with all four pHW2000 plasmids encoding the polymerase complex and the pHW72 luciferase reporter plasmid and incubated without tamoxifen. Tamoxifen-induced NS1 inhibits also viral gene expression. Shown is the quotient of the RLUs of cell lysates from tamoxifen induced versus noninduced cells. Vector control: MDCK cells containing an empty pEGZ vector served as control; PR8: MDCK cells expressing NS1ERT (PR8); SC35M: MDCK cells expressing NS1ERT (SC35M). Thai: NS1 originates from Thai/Kan; Panama: NS1 originates from Panama 99; SC35M: mutant NS1 F103S; mutant NS1 M106I; mutant NS1 184-188. (f) MDCK cells expressing NS1ERT SC35M were transfected with pCMV-luciferase and incubated without tamoxifen for 18 hr. Subsequently, total RNA was isolated and the expression of luciferase and some housekeeping genes were quantitatively analyzed via qRT-PCR using appropriate primers. To exclude that tamoxifen itself inhibits transcription empty vector, transduced MDCK cells were identically treated and analyzed for gapdh expression. The difference between the ct values was used to calculate the n-fold expression (2 Δct ) of the tamoxifen treated sample compared to nontreated cells (nontreated samples were set 100%). Lucifer: luciferase; gapdh: glycerinaldehyde dehydrogenase; hsp90: heat shock protein 90; rpl3: ribosomal protein L3; OHT: hydroxy-tamoxifen (0.5 μM). The experiments were repeated at least five times. * p value < .05 (n = 4, average and standard deviations are shown) cells induces both apoptosis and JNK phosphorylation, but the use of the two SC35M NS1 mutants, F103S and M106I, suggests that the two events can be separated.
At late stages of tamoxifen induction (48 hr), we observed reduced NS1ERT fusion protein expression (Figure 5a ), enhanced PARP cleavage, and increased JNK activation, even in the NS1 F103S ERT mutant-expressing cells (Figure 6a, right panel) . We assume that the reduction in NS1ERT protein level is due to a premature apoptotic degradation of this protein compared to others. In the case of unexpected JNK activation of the NS1 F103S ERT mutant in late stages, we speculate that JNK activation occurred at this late stage as a result of cellular stress due to progressed apoptosis, which has been previously induced by NS1.
2.4 | The effector domain (ED) of NS1 alone is able to induce apoptosis and JNK activation 
| DISCUSSION
To investigate the correlation between two NS1 effector functions, (a) JNK activation and (b) apoptosis induction, we established cell lines that stably express an inducible form of NS1. We chose a strategy that has been successfully applied in mouse transgenics using the CreERT2 recombinase, which is the sharpest tool to regulate Cre protein activity (Friedel et al., 2011) . This strategy has also been used to regulate the IAV that are discussed as being useful as live influenza vaccines (Mössler et al., 2013; Richt & García-Sastre, 2009 Van Wielink et al. (2011 reported similar results using a tetracycline-induced expression system. However, they failed to express NS1 of a subtype other than H5N9
(A/turkey/Wisconsin/68). Although we showed a decent level of complementation, the corresponding wild type viruses still achieved 10-to 100-fold higher titres indicating that ectopic expression of NS1 only partially complements the viral NS1 expression, probably because of less efficient expression or inappropriate timing of expression of the recombinant protein in the viral replication cycle.
In our inducible cell system, JNK activation is observed within the first hour upon tamoxifen addition. The SC35M NS1 F103S ERT mutant and the PR8 NS1ERT failed to activate JNK in contrast to the SC35M NS1 M106I ERT mutant, which is in line with the signalling events observed earlier in the course of IAV infection (Nacken et al., 2014) . In the MDCK NS1 M106I ERT cell line, the ERT-mediated blockade of NS1 seems to be somewhat leaky because JNK is phosphorylated in the noninduced state to a certain extent (Figure 5d ).
Tamoxifen-induced apoptosis was observed in all cells expressing wild type NS1ERT with the exception of cells expressing PR8 NS1ERT.
Both observations match reports that claim an antiapoptotic effect of PR8-NS1 and a proapoptotic effect of avian and most other NS1 proteins (Lam et al., 2008; Schultz-Cherry et al., 2001; Yan et al., 2016; Zhirnov et al., 2002) . In an attempt to quantify the cytopathic effect, we detected that PR8 NS1ERT and SC35M M106I and SC35M NS1
184-188 ERT failed to reduce luciferase activity upon tamoxifen addition, resulting in a loss of apoptogenicity. Thus, a single aa exchange at position 106 converted the apoptogenic SC35M NS1 into nonapoptogenic PR8 type NS1. However, in studies with IAV Udorn/72 (H3N2) mutations at identical positions in NS1, the apoptotic activity of a recombinant virus was enhanced compared to the wild type virus (Jackson, Killip, Galloway, Russell, & Randall, 2010) . Furthermore, the expression of NS1 from H7N9, which encodes an isoleucine at position 106, as NS1 of PR8 does, induces apoptosis (Yan et al., 2016) . The aa positions 106 and 184-188 of NS1 are known to play a crucial role in its binding to CPSF30 (Steidle et al., 2010; Twu, Noah, Rao, Kuo, & Krug, 2006) . Suppression of CPSF30 expression by siRNA inhibits lung cancer cell proliferation and induces apoptosis (Chen et al., 2013) . We speculate that CPSF30
inhibition by NS1 leads to apoptosis and that the IAV subtype-specific differences may thereby play a prominent role.
NS1 is reported to support viral transcription (Marc, 2014 review) .
Thus, we performed a minigenome assay in NS1ERT-expressing cells to further confirm that a functionally competent NS1 is released upon tamoxifen addition. Surprisingly, viral transcription in the tamoxifeninduced wild type NS1ERT-expressing cells was attenuated. The minigenome assay is based on the CMV-driven expression of the viral polymerase subunits. The expression of the polymerase subunits may similarly be attenuated as the CMV-driven luciferase activity resulting in a reduced transcription in the minigenome assay. Furthermore, NS1
may become functionally altered in some phases of infection by protein modifications such as phosphorylation or sumoylation that may not be properly controlled in our cell model (Santos et al., 2013; Kathum et al., 2015) .
We initiated this study with the aim of verifying or refuting the hypothesis that the NS1-mediated activation of JNK correlates with NS1-induced apoptosis. Tamoxifen induction of mutant SC35M M106I NS1ERT mediated JNK activation, but no signs of apoptosis were observed. On the other hand, mutant SC35M F103S NS1ERT, which has a strongly reduced capability to activate JNK, induced apoptosis. This indicates that these two NS1 effector functions are not necessarily linked to each other. At late stages of tamoxifen-stimulated SC35M F103S NS1ERT MDCK cells, JNK activation could also be observed ( Figure 6 ). However, at this stage, the NS1ERT fusion protein is already partially degraded, suggesting that JNK activation at this stage occurs independently of NS1, presumably as a result of cellular stress due to progressed apoptosis (Figure 5a ). Thus, we conclude that JNK activation in the early stage of infection represents an NS1 effector function that is independent of NS-mediated apoptosis induction. Once apoptosis progresses into late stages of infection, the apo- Notably, all viruses expressing NS1 mutants were more potent in inducing apoptosis compared to the wild type NS1-expressing IAV.
We currently have no explanation for this unexpected result. We also first, the viral RNA activates JNK in a RIG-I-dependent manner (Ludwig et al., 2002) . This pathway is suppressed by NS1, which binds viral RNA via its RBD and thus inhibits RIG-I activation. Second, expression of the NS1 effector domain originating from subtypes other than PR8
activates JNK (Yan et al., 2016) . (Kuo et al., 2016) .
In conclusion, the stable expression of an inducible IAV NS1
protein opens up novel opportunities to study NS1 functions. Using this cellular model, we showed that NS1-mediated JNK activation and NS1-induced apoptosis are independent from each other. (Feil et al., 1996) .
Reporter plasmid pTATA luc-IFN-β (Kathum et al., 2015) has been used to investigate the inhibition of interferon activation by NS1 fusion proteins. 
| Site-directed mutagenesis
Site-directed mutagenesis was performed using Phusion polymerase and phosphorylated primers according to the manufacturer's protocol (Thermo Scientific, Germany). Primers were purchased from MWG Biotech, Germany. all correspond to Canis lupus genes).
The difference of the ct-values between treated and nontreated cells was calculated (Δct), and the n-fold (2 Δct ) difference is shown.
The nontreated cells were set to 100. The experiment was repeated five times.
| Luciferase assays
Cells were trypsinised, washed by centrifugation, and transfected in suspension with 0.5 μg CMV luciferase reporter plasmid and 1 μl Lipofectamine 2000 (Invitrogen). Subsequently, cells were seeded into a 96-well plate (per 2 × 10 4 cells/well). After 4 hr, solvent was added to half of the wells, whereas 1 μM tamoxifen was added to the others.
Eighteen hours after transfection, cells were harvested, and luciferase activity was quantified using a luminometer (Lumat LB 9501) according to standard procedures (Ludwig et al., 2002) . 
| Retroviral transduction
The pEGZ plasmids encoding NS1-ERT fusion proteins (NS1ERT) were transfected into the packaging cell line Phoenix ampho. The supernatants were used to transduce MDCK, A549, and HEK293 cells. Because pEGZ transduction confers resistance to zeocin, cells were incubated in medium containing the selective antibiotic zeocin (200-400 μg/ml depending on cell line). After 4 weeks of selection, the resulting cells were kept under 100 μg/ml zeocin to maintain selective pressure. Subsequently, the expression of an NS1ERT fusion protein was verified.
Zeocin-resistant cells transduced with a supernatant from an empty-vector-transfected packaging cells served as control cells.
| Apoptotic DNA ladder
Cells (1.5 × 10 6 ) were incubated without tamoxifen for 24 hr in six-well plates for the time indicated. Subsequently, cells were resuspended in lysis buffer (50 mm Tris-HCl (pH 8.0), 10 mm EDTA, 0.3% Triton X-100) for 30 min on ice. After centrifugation at 15,000 rpm for 5 min, the cytosolic supernatant was treated with RNase (100 μg/ml) for 30 min at 55°C and then with proteinase K (400 μg/ml) for at least 1 hr or overnight at 55°C. Subsequently, the DNA was extracted from cell lysates with phenol-chloroform and precipitated with ethanol and finally electrophoresed on 2% agarose gels containing ethidium bromide.
4.9 | Generation of recombinant viruses encoding mutated and Myc-tagged NS1
All recombinant viruses described here are based on H7N7 IAV SC35M and were generated according to the method of Hoffmann, Neumann, Kawaoka, Hobom, and Webster (2000).
NS segment of SC35M was recombinantly reconstructed following the cloning strategy of Perez et al. (2013) . Briefly, a silent mutation was introduced into the splice acceptor site of NS1 at position 537 to prevent splicing. Subsequently, the 5′ noncoding sequence and the NS1-coding sequence (omitting the stop codon) were fused to a Myc-tag and the porcine teschovirus 2A peptide-coding sequences to the NS1 C-terminus. Finally, the NS2 including the 3′ noncoding sequence of the NS segment was cloned behind the 2A peptide (Figure 8a ) and the whole recombinant segment inserted into pHW2000. This segment allows the introduction of any mutation into the NS1 sequence without affecting NS2 expression. To generate NS1
that was deficient for the RBD, we mutated the first four in frame and out of frame ATGs to ATC, thereby generating an NS1 that starts with the methionine at position 79 and which is devoid of the RBD. Furthermore, position F103S and M106I of NS1 were mutated as described (Nacken et al., 2014) . NS segments encoding C-terminal deleted NS1
proteins (aa1-79 and aa1-108) were generated by PCR.
